Short duration sedation;Sedación de corta duración

Medicina Intensiva

Volumn 32, Issue SUPPL. 1, 2008, Pages 12-18

  Borrallo Perez J M ^a,c   Bejar Delgado A ^b  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

^c NONE   (Spain)

Author keywords

Critically ill patients; Ketamine; Midazolam; Opiates; Propofol; Remifentanil; Short sedation

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; CIMETIDINE; CLARITHROMYCIN; ERYTHROMYCIN; FLUCONAZOLE; ITRACONAZOLE; KETAMINE; MIDAZOLAM; PHENYTOIN; PROPOFOL; REMIFENTANIL; RIFAMPICIN;

ANALGESIA; ARTIFICIAL VENTILATION; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG METABOLISM; DRUG SELECTIVITY; HUMAN; INTENSIVE CARE UNIT; PATIENT SELECTION; RECOMMENDED DRUG DOSE; REVIEW; SEDATION;

ANESTHETICS, INTRAVENOUS; DEEP SEDATION; HUMANS; KETAMINE; MIDAZOLAM; PIPERIDINES; PROPOFOL; TIME FACTORS;

EID: 45749107628     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Blanco J, Martínez JM, Collado J. Sedación con benzodiacepinas en el paciente grave. En: Castañeda FJ, editor. Sedación y analgesia en el paciente grave. Medicina crítica práctica. Barcelona: Edika Med; 1994. p. 39-56.
2. Amrein R, Hetzel W. Pharmacology of drugs frecuently used in ICUs: midazolam and flumazenil. Intensive Care Med. 1991;17 Suppl 1:S1-10.
3. Young CC, Prielipp RC. Benzodiazepines in the intensive care unit. Crit Care Clin. 2001;17:843-62.
4. Bauer TM, Ritz R, Haberthur C, Ha HR, Hunkeler W, Sleight AJ, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet. 1995;346:145-7.
5. Chamorro C, Romera MA, Márquez J, Pardo C, Valdivia M. Therapeutic failure with midazolam in the sedation of critical patients. A definition proposal. Intensive Care Med. 2004;30 Suppl 1:S177.
6. Chamorro C, Romera MA, Estecha MA, Rubio JJ. Sedación en Cuidados Intensivos. Nuevos fármacos para nuevas tendencias. Med Intensiva. 1994;18:164-72.
7. Song D, Hamza MA, White PF, Byerly SI, Jones SB, Macaluso AD. Comparison of a lower-lipid propofol emulsion with the standard emulsion for sedation during monitored anesthesia care. Anesthesiology. 2004;100:1072-5.
8. Conejero R, García de Lorenzo A, Acosta J, López- Martínez J, Serralta MJ. Sedación en Cuidados Intensivos: comparación de las concentraciones de propofol al 1% y al 2%. Med Intensiva. 1999;23:114-9.
9. Fulton B, Sorkin EM. Propofol: an overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs. 1995;60:636-57.
10. Chamorro C, Rubio JJ, Romera MA, Nieto M, Luque P, Estecha MA. Propofol. Revisiones de conjunto. An C Intensivos. 1991;6:42-8.
11. McKeage K, Perry CM. Propofol. A review of its use in Intensive Care sedation of adults. CNS Drugs. 2003;17:235-72.
12. Riker RR, Fraser GL. Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the Intensive Care Unit. Pharmacotherapy. 2005;25:S8-18.
13. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003;29:1417-25.
14. Anneta MG, Jemma D, Garisto C, Tafani C, Proietti R. Ketamine: new indications for an old drug. Curr Drug Targets. 2005;6:789-94.
15. Kohrs R, Durieux ME. Ketamine: teaching and old drug new tricks. Anesth Analg. 1998;87:1186-93.
16. Strube PJ, Hallam PL. Ketamine by continous infusion in status asthmaticus. Anaesthesia. 1986;41:1017-9.
17. Castañeda J. Farmacocinética y farmacodinámica del remifentanilo. Med Intensiva. 2003 Supl;1:10-3.
18. Martínez-Melgar JL, Piñeiro N, Alemparte E. Remifentanilo. Experiencia en sedoanalgesia de corta duración. Med Intensiva. 2004 Supl;2:5-9.
19. Grounds RM, Lalor JM, Lumley J, Royston D, Morgan M. Propofol infusion for sedation in the intensive care unit. Br Med J. 1987;294:397-400.
20. McMurray TJ, Collier PS, Carson IW, Lyons SM, Elliot P. Propofol sedation after open heart surgery. A clinical and pharmacokinetic study. Anaesthesia. 1990;45:322-6.
21. Roekaerts PM, Huygen FJ, de Lange S. Infusion of propofol versus midazolam for sedation in the intensive care unit following coronary artery surgery. J Cardiothorac Vasc Anesth. 1993;7:142-7.
22. Sherry K, McNamara J, Brown JS, Drummond M. An economic evaluation of propofol/fentanyl compared with midazolam/fentanyl on recovery in the ICU following cardiac surgery. Anaesthesia. 1996;51:312-7.
23. Aitkenhead AR, Pepperman ML, Willatts SM, Coates PD, Park GR, Bodenham AR, et al. Comparison of propofol and midazolam for sedation in critically ill patients. Lancet. 1989;II:704-9.
24. Boyd O, Mackay CJ, Rushmer F, Bennet ED, Grounds RM. Propofol or midazolam for short-term alterations in sedation. Can J Anesth. 1993;40:1442.
25. Carrasco G, Molina R, Costa J, Soler JM, Cabre L. Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis. Chest. 1993;103:557-64.
26. Costa J, Cabré L, Molina R, Carrasco G. Cost of ICU sedation. Clin Intensive Care. 1994;5 Suppl 5:17-21.
27. Ronan KP, Gallagher TJ, George B, Hamby B. Comparison of propofol and midazolam for sedation in intensive care unit patients. Crit Care Med. 1995;23:286-93.
28. Kress JP, O'Connor MF, Pohlman AS, Olson D, Lavoie A, Toledano A, et al. Sedation of critically ill patients during mechanical ventilation: a comparison of propofol and midazolam. Am J Respir Crit Care Med. 1996;153:1012-8.
29. Hall RI, Sandham D, Cardinal P, Tweeddale M, Moher D, Wang X, et al. Propofol vs midazolam for ICU sedation. A Canadian Multicenter randomized trial. Chest. 2001;119:1151-9.
30. Anis AH, Wang X, Leon H, Hall R. Economic evaluation of propofol for sedation of patients admitted to intensive care units. Anesthesiology. 2002;96:196-201.
31. Higgins TL, Yared JP, Estafanous FG, Coyle JP, Ko HK, Goodale DB. Propofol versus midazolam for intensive care unit sedation after coronary artery bypass grafting. Crit Care Med. 1994;22:1415-23.
32. Searle NR, Cote S, Taillefer J, Carrier M, Gagnon L, Roy M, et al. Propofol or midazolam for sedation and early extubation following cardiac surgery. Can J Anaesth. 1997;44:629-35.
33. Walder B, Elia N, Henzi I, Romand J, Tramer MR. A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: A qualitative systematic review. Anesth Analg. 2001;92:975-83.
34. Carrasco G, Cabre L, Sobrepere G, Costa J, Molina R, Cruspinera A, et al. Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery bypass grafting. Crit Care Med. 1998;26:844-51.
35. Walder B, Borgeat A, Suter PM, Romand JA. Propofol and midazolam versus propofol alone for sedation following coronary artery bypass grafting: a randomized, placebo-controlled trial. Anaesth Intensive Care. 2002;30:171-8.
36. Soltesz S, Biedler A, Silomon M, Schopflin I, Molter GP. Recovery after remifentanil and sufentanil for analgesia and sedation of mechanically ventilated patients after trauma or mayor surgery. Br J Anaesth. 2001;86:763-8.
37. Muellejans B, Matthey T, Scholpp J, Schill M. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial. Critical Care. 2006;10:R91.
38. Karabinis A, Mandragos K, Stergiopoulos S, Komnos A, Soukup J, Speelberg B. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial. Critical Care. 2004;8:R268-80.